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| Summary |
Based on two individual cases, this is a personal depict 
on knowledge of Idiopathic Parkinson´s Disease (IPD) 
etiopathogeny emphasizing diets, food and edible substances 
tested and reported. In the first case (adherence to an almost 
vegan diet, with one seventh of the protein supplied from 
animal origin), had an impressive beneficial effect on 
his fifteen years clinical course, while in the second case 
(continuation of a quasi ovo-lacto-vegetarian diet), did not 
modify substantially the clinical course. The relevance of diet 
on IPD focused in redistribution of protein daily intake when 
levodopa prescribed. Diet by itself is fundamental for the 
management of each individual person prone to or suffering 
from IPD. Vegan diets with pulses rich in protein duly balanced 
with cereals and supplemented with vitamin B12, reduce the 
intake of methionine and keep the amount of aromatic amino 
acids at a moderate level.
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Resumen
A partir de dos casos individuales, se presenta un esbozo personal 
sobre el conocimiento de la etiopatogenia en la Enfermedad 
de Parkinson Idiopática (EPI), con un énfasis en las dietas, la 
comida y las sustancias comestibles probadas y reportadas. En 
el primer caso (adherencia a una dieta prácticamente vegana, 
con una séptima parte de la proteína suplida de productos de 
origen animal), tuvo un impresionante efecto benéfico en sus 
quince años de desarrollo clínico, mientras que en el segundo 
caso (que siguió una dieta casi ovo-lacto-vegetariana) no se 
modificó sustancialmente el desarrollo clínico. La relevancia de 
la dieta en la EPI se concentra en la redistribución diaria de la 
ingesta de proteínas cuando se ha prescrito levodopa. La dieta 
por sí misma es fundamental para el manejo de cada persona 
predispuesta o que sufre de EPI. Las dietas veganas, ricas en 
proteínas debidamente balanceadas con cereales y suplementadas 
con vitamina B12, reducen la ingesta de metionina y mantiene la 
cuenta de aminoácidos aromáticos a un nivel moderado.
Palabras clave: Enfermedad de Parkinson, Dieta, Dieta 
Vegetariana, Metionina, Prevención de Enfermedades (DeCS). 
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Introduction
The six patients described by James Parkinson (1) as afflicted 
by Shaking Palsy, motivated Jean Marie Charcot to label them 
as suffering Parkinson´s disease (2), yet this syndrome would 
have been a better choice with its classic triad: tremor, stiffness 
and slowness. A large number of other non-motor afflictions 
add to the protracted clinical course of each patient. 
Idiopathic Parkinson´s Disease (IPD) is more prevalent in 
countries with high industrial development and high economic 
standards. However, there have been studies linking higher 
incidence of Parkinson’s among rural inhabitants as compared 
to urban residents. Nowadays it is apparent that there are 
several distinct types of parkinsonian disorders (3) and each 
patient individually endures his lot.  
Discussing its “origin”, Parkinson stated, “we are led to 
seek for it in some slow morbid change in the structure of 
the medulla” (1). It is well established that damage of the 
substantia nigra (SN) melanic neurons, more severe in its 
pars compacta, is responsible for the motor signs of IPD and 
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in such cases cell loss is substantial and done over several 
years before overt clinical signs appear (3,4). 
Among causal agents of Parkinsonism, the lethargic 
encephalitis virus was prominent after the influenza pandemic 
of 1919 with many cases of its postencephalitic form, mostly 
with rigidity and bradikynesia. Several exogenous toxic agents 
(reserpine, manganese, MPTP, substances in the leaves of 
the sour sop tree Annona muricata L) cause Parkinsonism or 
closely related syndromes. The endogenous toxins causing 
the development of IPD signs and symptoms are methylated 
abnormal intermediates akin to those of dopamine secondary 
metabolites (4): in persons prone to IPD their very low tyrosine-
hydroxylase (TH) activity leaves a local abundance of both 
tyrosine and tyramine (its decarboxylation product) available 
for abnormal reactions amongst them methylation. 
Tyramine is produced in excess and is excreted in the urine, 
though in other cases is further metabolized and is excreted 
in lower amount than by normal persons (5). The resulting 
abnormal metabolites metabolize in an unknown way. The 
reason why the extention of those metabolites is responsible 
for the SN damage is also unknown. Matsubara (6), Naoi 
(7) and Williams (8) propose several abnormal methylated 
substances as SN neurotoxins. The last author considers 
IPD as an autointoxication related to N-methylnicotinamide. 
People susceptible to IPD submitted in addition to exogenous 
neurotoxins will develop their IPD earlier and more severely.  
During the last decades, the genetics for Parkinsonism have 
been studied and many different genes have been located (3). 
Some early onset (or young onset) of Parkinsonism have a direct 
genetic component, while several genes have been scrutinized 
in idiopathic cases (nowadays called “sporadic”), by far more 
frequent. Two different mutations in LRRK2 dardarin (the 
euskera name for tremor), R1441G in Basques and some of 
them also carry mutation G2019S present in Ashkenazis (9). 
The study of these remarkable ethnic groups should give many 
answers for the prevention of the Parkinson´s syndrome.
Materials and methods 
The study counted with two cases: 
Case 1
An Ashkenazi man developed his Parkinsonism at the age of 
67 (10). He was able to function for about 42 months from the 
time of diagnosis, without drugs for his Parkinson´s disease. 
Constant loss of weight in the fourth year necessitated turning 
to levodopa, and his weight brought up (15 lbs over 3 months). 
Thereafter, sinemet (levodopa/carbidopa) (100/25 3/day) was 
taken and increased annually.  
Roughly three years after being on drugs for IPD, he found 
one morning there was no response after taking the usual 
doses of levodopa/carbidopa and entacapone. Recalling some 
readings about interference of animal protein with absorption 
of Parkinson´s disease medicaments and checking two texts 
on PD that corroborated this fact, he had a vegan lunch and 
was overwhelmed at the significant difference in his body’s 
response. This was a powerful motivator.  Further reading led to 
understand that a meal with 87% whole grains and vegetables/
fruit with the remainder animal protein, works well. This was 
also the first time in four years that there was no need to increase 
the PD drugs after one year on the semi-vegan diet. 
In his 75th year, on his eighth year of clinical course, the 
patient completed 2 years on quasi-vegan diet. In that period, 
clinical signs of the disease did not appear to have advanced, 
levodopa dosage remaining the same, and incremental 
improvement benefited quality of life. He passed away on 
January 2011 at the age of 82.  
Case 2
A basque woman, mother of three children, two of them 
afflicted with essential tremor, and grandmother of eleven 
grandchildren, started her IPD clinical signs at the age of 84 
(11). She had a mild tremor of her left hand fingers. Along her 
life she had been very moderate at table, so her siblings called 
her “chupa huesos” (bone sucker) because when young she 
asked for bones with very little meat. On the other side she 
indulged in milk and eggs (thrice a day plus those entering in 
making her most delicious “flan”, a gel prepared by heating 
milk, eggs and sugar, readily consumed) so she could be 
considered a not too strict ovo-lacto-vegetarian. For years, she 
took a vitamin supplement with a substantial amount of iron. 
Her clinical course lasted ten years and was steadily downhill 
in spite of her very good response during the last six years to 
low doses of sinemet or madopar. While shifting proteins on the 
last meal has also been proposed (3), in her case little protein 
in the last meal plus minimal doses of sinemet (levodopa/
carbidopa) or madopar (levodopa/benserazide) in the evening 
induced a restful sleep overnight. 
Pubmed database was consulted to identify investigations 
about diets, food and natural substances in relation with 
Parkinson´s disease. 
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Results
Table 1 lists diets and food reported along with IPD. A 
reference was given whenever a thorough review has been 
Palacios (12) reported that IPD patients were heavier and 
had more fat in their bodies: this can be assume as the result 
of overeating and/or not enough physical exercise. On the 
other hand, several studies show that IPD patients can lose 
weight, as in case 1 disease (10), and many like Perpe (11) 
have problems to swallow their meals.
Dairy products are correlated with higher incidence of 
IPD (20). Chen (29) concluded that: “Our results suggest that 
higher intake of dairy products may increase the risk of PD 
in men; however, this finding needs further evaluation, and 
the underlying active components need to be identified”. On 
the contrary, a paper from Japan (28) reported no difference; 
other dietary factors in the usual Japanese diet (rice, soy beans) 
should be considered. A most recent article from Greece 
correlates statistically milk consumption with higher incidence 
but neither yoghurt nor cheese (30) showed this correlation. 
Mixing two different experimental variables make 
uncertain the evaluation of the results observed, as in the 
study by Coimbra and Junqueira (15) who suppressed red 
meat from the diet of their IPD patients and overloaded them 
with riboflavin. They observed clinical improvement but the 
statistical design was later severely disputed; yet evaluating 
two variables would have required additional control groups 
for each variable. Animal fat has been taken in consideration 
(17) disregarding the amount of meat ingested along with it.
Cotzias and cols., found in their studies with levodopa that 
animal protein had a clear effect on their patients: “hamburgers” 
caused worsening of the signs in some of them (16,31). They 
proposed that “neutral” amino acids compete with levodopa 
in transport systems, but hypothesized “levodopa is perhaps 
doing something more permanent than merely supplying 
readily consumable materials to the brain” (33). Since then, 
all the attention directs to distribute protein intake in such a 
way as to avoid interference with the absorption of levodopa 
and its entrance into the central nervous system. An individual 
case (10) reported the good effect of restricting animal protein 
to around one seventh of the protein provided in the diet. The 
published. Table 2 lists the natural substances in the diet 
related to IPD. 
Table 1
DIETS, FOODS AND PARKINSON EFFECTS OBSERVED TYPE OF STUDY AUTHORS
Excessive alimentary intake (overweight, adiposity)  Increased incidence Statistical Palacios (12)
Low protein intake Improvement Clinical Mena (13)
Protein redistribution Improvement Clinical Cereda (14)
Exclusion of red meat Improvement Clinical Coimbra (15)
Meat meals Aggravation Clinical Langan (16)
Animal fat Increased incidence Statistical Anderson (17)
Blubber and pilot whale meat Increased incidence Statistical Petersen (18)
Sheep meat Increased incidence Statistical Komatsu (19)
Dairy products intake by males Increased incidence Statistical Ishihara (20)
Quasi vegan diet Improvement Clinical Schwartz (10)
Restricted diet low  animal fat no fat milk products No improvement Clinical Renoudet (21)
Plant protein diet Improvement Clinical Baroni (22)
Horse bean, broad bean, faba bean (vicia faba l) Improvement Clinical Rabey (23)
Velvet bean (mucuna pruriens (l) dc. var. utilis Improvement Clinical Katzenschlager (24)
Coffee (coffea arabiga l) infusion of roasted seeds Lower incidence Statistical Ishihara (20)
Tea (camellia sinensis l) infusion of leaves Lower incidence Statistical Tanaka (25)
Soybeans (glycine mas   ) cooked seeds Lower incidence Statistical Fukushima (26)
Corn (zea mays l) seeds Lower incidence Statistical Fukushima (26)
Tomatoes  (lycopersicon esculentum miller) fruits, sauces Lower incidence Statistical Nielsen (27)
Potatoes (solanum tuberosum l), tubercles Lower incidence Statistical Nielsen (27)
Vegetables, green, yellow and others No material relationship Statistical Miyake (28)
Source: author.
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case reported by Renoudet (21) did not show an improvement 
by the decrease of “animal fat” consumption and non-fat milk 
products, but an amelioration resulted when eating fisetin (a 
tetrahydroxyflavone present in strawberries and many plants: 
CAS 528-48-3) and hexacosanol (a long chain aliphatic 
alcohol CAS 506-52-5 present in wheat germ and many other 
food items). 
Meat in addition to high levels of methionine (MET) and 
aromatic amino acids (AAA) contains several methylated 
substances (carnitine, creatine, phosphocreatine, betaine, 
choline, acetylcholine, sarcosine) that can contribute with 
methyl groups for the recycling of homocysteine; this affects 
the MET accounting even up to the half of its daily requirement 
in the diet. 
Very little attention has been paid (3) to Langan and Cotzias 
warning (16): “The foods to limit include milk, meat, fish, 
poultry, cheese, eggs, whole grains and soy bean products” 
and they illustrated their paper with a drawing of a man 
running away from them. A report by Cotzias team clarify 
however that, “the fact that some patients and their relatives 
have demanded low-protein diets on a long-term basis does 
not change the experimental status of those regimens” (31).  
A number of plant food and substances found in them match 
with lower incidence or to improve the course of IPD patients. 
Only recent replacement of animal protein by plant protein, as 
achieved by following a vegetarian diet, showed a clear-cut 
clinical improvement of IPD patients: Baroni (22) performed 
an experiment shifting from omnivorous to vegetarian diets 
a group of twelve patients with Parkinson´s disease who 
improved on the latter regimen. Plants like the broad bean (23) 
and the velvet bean (24) contain levodopa. Nielsen ascribes 
(27) the effect of solanaceous plants in diets to their nicotine 
content (32) disregarding other substances contained, mostly 
in tomatoes, and other components in those diets.  
The decrease in MET and AAA ingestion by vegetarians 
that exclude dairy products explains these findings. The 
overload of MET and AAAs can also explains the coincidence 
of high dairy products consumption with increased number 
of IPD persons.
Table 2. Natural substances in the diet related to IPD.
NATURAL SUBSTANCES AND PARKINSON EFFECT OBSERVED METHOD AUTHOR
Levodopa Improvement Clinical Birkmayer (34)
Caffeine Lower incidence Statistical Ishihara (20)
Ethanol Lower incidence Statistical Ishihara (20)
Methionine Aggravation Clinical Pearce (35)
Methionine Improvement Clinical Meininger (36)
Tryptophan + levodopa Improved mood Clinical Coppen (37)
Tryptophan + pyridoxine Aggravation Clinical Hall (38)
5-hydroxytryptophan Aggravation Clinical Chase (39)
Creatine Neuroprotective Clinical Beal (40)
N-methylcysteine (cabbage, turnips,garlic) Prevention motor signs Experimental Wassef (41)
N-acetylcarnitine Improved sleep signs Clinical Puca (42)
Fisetin  + hexacosanol Improvement Clinical Renoudet (21)
Nicotine Lower incidence Statistical Ishihara (20)
Pyridoxine (vitamin b 6) Blocks levodopa Clinical Mars (43)
Pyridoxine (vitamin b 6) low intake Higher incidence Statistical Murakami (44)
Vitamin e, betacarotene May be associated Statistical Miyake (28)
Folic acid Unimpresive Clinical Mcgeer (45)
Iron Possible positive association Statistical Ishihara (20)
Calcium No significant association Statistical Ishihara (20)
Manganese Causes parkinsonism  Clinical Cotzias (46)
Vitamins No significant associations Statistical Ishihara (20)
Source: author.
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The impressive motor improvement of most IPD patients 
when taking levodopa (34) and the relation of this action with 
the timing of eating protein has been clearly established and 
diet instructions have been imparted to IPD patients basically 
as an adjunct to levodopa treatment. This is accepted as the 
result of better absorption of levodopa when not competed by 
other amino acids both at the intestinal absorption sites and 
at the blood brain transport systems. The redistribution of 
protein ingestion during the day increases the absorption of 
levodopa both in the gastrointestinal tract and by neurones, by 
less competed transport through the blood brain barrier (BBB). 
Each substance listed, starting with levodopa, deserves 
additional studies to determine their mechanism of action. 
Methionine is implicated in the dopamine secondary 
metabolism to synthesize endogenous morphine (4) and has 
been shown to be damaging to IPD patients receiving levodopa 
(35), though a preliminary report of a trial (36) claimed that 
it was as effective as levodopa. No subsequent reports have 
been founded on this matter by these authors, though Zhu 
(47), based on some concepts, proposes to supplement a diet 
rich in fruits and vegetables with S-adenosylmethionine. 
Beal (40) states that: “A phase 2 futility trial in PD showed 
approximately a 50% improvement in Unified Parkinson’s 
Disease Rating Scale at one year, and the compound [carnitine] 
was judged to be non futile.”
Discussion
The pharmacologic treatment of Parkinsonism is 
considered paramount; because of that, physiotherapy and 
diet have little consideration on the attention of the disease. 
Both of them are fundamental for the wellbeing of IPD 
patients. Indeed, Singer (48) does not mention the latter and 
gives a forty words mention to the former. Sääksjärvi and 
Knekt (49) suggest that “…since most of the single food 
groups or the quality of diet did not predict PD occurrence, 
the role of diet is apparently rather modest”. However, 
they found that low meat and high dairy eating by women 
positively correlated with Parkinson´s disease, and do not 
give a global evaluation of animal protein ingested. No 
report compares a pulse rich diet with catechol orthomethyl 
transferase (COMT) inhibitors on levodopa metabolism and/
or clinical response. 
Alcalay paper (50) points out that “greater Mediterranean 
diet adherence was associated with later PD age-at-onset” 
and starts the discussion of results stating that: “lower 
adherence to Mediterranean diet is associated with PD 
status…the fact that among PD participants lower adherence 
was associated with earlier PD age-at-onset further suggests 
a possible dose-response effect”.
Conclusion
Based in the limited, but in-depth, personal experiences, 
diet has a primary importance and must be the first step 
in prevention and treatment of IPD: it is fundamental for 
people (1-2%) enduring, or susceptible to, IPD invalidating 
conditions.    
The “do not” (15) items (animal protein, including milk and 
cheeses), which are usually high in MET and AAA, should 
be very few in the diet of IPD patients (and of those prone 
to this ailment, whenever a preclinical diagnostic method 
becomes available). On the positive side their diet must be 
abundant in fruits, vegetables and, on a calculated proportion, 
pulses (common beans, soya bean, lentils, chickpeas, etc.), all 
of them low in methionine, combined with cereals (as done 
traditionally in Mexico), which level the relative amount of 
methionine with that of lysine, deficient particularly in maize 
(indian corn=Zea mays L). 
A diet like that is healthier than a diet that depends on 
animal products with an excess of essential aminoacids. The 
sufficient amount of calories must be provided as well as 
vitamin B 12 in adequate dosage. It is urgent to carry on studies 
on the prevalence of IiPD in vegetarians, comparing them with 
omnivorous and carnivorous persons. These studies should be 
performed in Basques and Ashkenazi, carriers of mutation at 
LRRK2, correlating their diet to age of IPD signs onset. Those 
patients should start vegetarian diets, with minimal amounts 
of dairy products and eggs, as soon as possible and feasible.
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